drugset / Trial / NCT00501241
Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether ATI-7505 is effective in the treatment of chronic idiopathic constipation.
Timeline
- Start
- 2007-07
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATI-7505 | Unknown | 20 mg | — |
| Subject | ATI-7505 | Unknown | 40 mg | — |
| Subject | ATI-7505 | Unknown | 80 mg | — |
| Subject | ATI-7505 | Unknown | 120 mg | — |